ENZ Enzo Biochem Inc

  1. Stocks
  2. Healthcare
  3. NYSE: ENZ

Price (delayed)

$3.62

Market cap

$175.47M

P/E Ratio

120.67

Dividend/share

N/A

EPS

$0.03

Enterprise value

$190.49M

Enzo Biochem is a pioneer in molecular diagnostics, leading the convergence of clinical laboratories, life sciences and intellectual property through the development of unique diagnostic platform technologies that provide numerous ...

Highlights
The gross profit has soared by 132% YoY and by 29% from the previous quarter
The EPS has soared by 114% from the previous quarter and by 105% YoY
Enzo Biochem's debt has increased by 13% YoY but it has decreased by 3.5% QoQ
Sector: Healthcare
Industry: Diagnostics & Research
Website: http://www.enzo.com
Peers: BRLI RDNT DGX LH

Key stats

What are the main financial stats of ENZ
Market
Shares outstanding
48.47M
Market cap
$175.47M
Enterprise value
$190.49M
Valuations
Price to earnings (P/E)
120.67
Price to book (P/B)
2.69
Price to sales (P/S)
1.56
EV/EBIT
151.06
EV/EBITDA
49.38
EV/Sales
1.69
Earnings
Revenue
$112.45M
EBIT
$1.26M
EBITDA
$3.86M
Free cash flow
-$9.1M
Per share
EPS
$0.03
Free cash flow per share
-$0.19
Book value per share
$1.35
Revenue per share
$2.32
TBVPS
$2.19
Balance sheet
Total assets
$113.62M
Total liabilities
$48.66M
Debt
$30.11M
Equity
$64.97M
Working capital
$42.13M
Liquidity
Debt to equity
0.46
Current ratio
2.44
Quick ratio
1.93
Net debt/EBITDA
3.89
Margins
EBITDA margin
3.4%
Gross margin
45.9%
Net margin
1.1%
Operating margin
-0.1%
Efficiency
Return on assets
1.1%
Return on equity
2.1%
Return on invested capital
1.9%
Return on capital employed
1.5%
Return on sales
1.1%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

ENZ stock price

How has the Enzo Biochem stock price performed over time
Intraday
4.32%
1 week
3.72%
1 month
18.69%
1 year
52.74%
YTD
43.65%
QTD
14.2%

Financial performance

How have Enzo Biochem's revenue and profit performed over time
Revenue
$112.45M
Gross profit
$51.61M
Operating income
-$157,000
Net income
$1.28M
Gross margin
45.9%
Net margin
1.1%
The gross profit has soared by 132% YoY and by 29% from the previous quarter
Enzo Biochem's net income has soared by 112% from the previous quarter and by 104% YoY
Enzo Biochem's net margin has surged by 110% QoQ and by 103% YoY
The operating margin has soared by 100% YoY and by 99% from the previous quarter

Growth

What is Enzo Biochem's growth rate over time

Valuation

What is Enzo Biochem stock price valuation
P/E
120.67
P/B
2.69
P/S
1.56
EV/EBIT
151.06
EV/EBITDA
49.38
EV/Sales
1.69
The EPS has soared by 114% from the previous quarter and by 105% YoY
The P/B is 35% more than the last 4 quarters average of 2.0 but 7% less than the 5-year quarterly average of 2.9
ENZ's equity is up by 5% from the previous quarter and by 4.2% YoY
The company's revenue rose by 45% YoY and by 16% QoQ
The P/S is 35% below the 5-year quarterly average of 2.4 but 20% above the last 4 quarters average of 1.3

Efficiency

How efficient is Enzo Biochem business performance
ENZ's ROA has soared by 112% since the previous quarter and by 104% year-on-year
ENZ's ROE has soared by 112% QoQ and by 105% YoY
The ROS has soared by 110% from the previous quarter and by 103% YoY
The ROIC has soared by 110% from the previous quarter and by 103% YoY

Dividends

What is ENZ's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for ENZ.

Financial health

How did Enzo Biochem financials performed over time
ENZ's total assets is 134% greater than its total liabilities
The total liabilities has contracted by 10% YoY and by 3.2% from the previous quarter
The current ratio has grown by 7% YoY and by 4.7% from the previous quarter
Enzo Biochem's debt is 54% lower than its equity
Enzo Biochem's debt has increased by 13% YoY but it has decreased by 3.5% QoQ
The debt to equity has contracted by 10% from the previous quarter but it has grown by 7% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.